Core Alternative Capital’s Charles Schwab SCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
2,973
+435
+17% +$39.7K 0.08% 103
2026
Q1
$239K Buy
2,538
+390
+18% +$38.2K 0.07% 106
2025
Q4
$215K Buy
2,148
+1,711
+392% +$162K 0.06% 107
2025
Q3
$41.7K Hold
437
0.01% 134
2025
Q2
$39.9K Hold
437
0.01% 136
2025
Q1
$34.2K Sell
437
-1,090
-71% -$85.5K 0.01% 148
2024
Q4
$113K Hold
1,527
0.02% 119
2024
Q3
$99K Buy
1,527
+135
+10% +$8.87K 0.02% 121
2024
Q2
$103K Hold
1,392
0.02% 120
2024
Q1
$101K Sell
1,392
-620
-31% -$40.8K 0.02% 120
2023
Q4
$138K Buy
2,012
+175
+10% +$10.1K 0.02% 119
2023
Q3
$101K Buy
1,837
+550
+43% +$33.2K 0.02% 144
2023
Q2
$72.9K Buy
1,287
+121
+10% +$6.34K 0.01% 135
2023
Q1
$61.1K Buy
1,166
+491
+73% +$36K 0.01% 148
2022
Q4
$56.2K Sell
675
-47
-7% -$3.65K 0.01% 149
2022
Q3
$52K Buy
722
+53
+8% +$3.68K 0.01% 145
2022
Q2
$42K Sell
669
-8
-1% -$552 0.01% 160
2022
Q1
$57K Buy
677
+612
+942% +$53.8K 0.02% 140
2021
Q4
$5K Buy
+65
New +$5.26K ﹤0.01% 190

Other funds holding SCHW

Core Alternative Capital's SCHW Position: Q2 2026 in Review

Core Alternative Capital increased its Charles Schwab (SCHW) stake by 17% in Q2 2026, buying an estimated $39.7K and bringing the position to 2,973 shares worth $274K. The position accounts for 0.08% of the portfolio, ranked #103.

Core Alternative Capital first reported a position in SCHW in Q4 2021 and has held it in 19 quarters since. 2,311 funds tracked by Wall St. Rank hold SCHW as of Q2 2026.

  • Core Alternative Capital held 2,973 shares of Charles Schwab worth $274K as of Q2 2026.
  • Core Alternative Capital bought 435 Charles Schwab shares in Q2 2026, an estimated $39.7K.
  • Charles Schwab made up 0.08% of Core Alternative Capital's portfolio in Q2 2026, its #103 holding.
  • Core Alternative Capital first reported a position in Charles Schwab in Q4 2021 and has held it in 19 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Charles Schwab as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.